Literature DB >> 8965593

[Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors].

J K Seifert1, T Junginger.   

Abstract

Between September 1985 and December 1994, liver resections with curative intent were performed for liver metastases of colorectal primaries in 76 patients at the department for abdominal surgery of the university of Mainz. Perioperative morbidity and 30-day mortality rates were 30.3% and 6.6% respectively. The 3- and 5-year survival rate was 53% and 36% respectively. For patients with complete tumor removal (R0 resection), excluding perioperative mortality, the following factors were associated with more prolonged survival after hepatic resection in univariate analysis. N1 stage of the colorectal primary compared to N2 stage (in patients with positive mesenterial lymph nodes); diameter of the largest metastasis between 2.1 and 3.5 cm; postoperative normalized CEA level (in patients with CEA level elevated to more than 4 ng/dl preoperatively); and wedge resections compared to hemihepatectomies. Regarding disease-free survival, only N1 stage of the colorectal primary compared to N2 stage and diameter of the largest metastasis between 2.1 and 3.5 cm had a positive influence. In multivariate analysis, the diameter of the largest metastasis was the only factor associated with survival time, while disease-free survival was influenced by the largest diameter of the metastasis, patient sex and N stage of the colorectal primary. Whether adjuvant therapies (systemic or regional chemotherapy) after curative resection of colorectal liver metastases is associated with better survival times remains an open question. Some of the above-mentioned prognostic factors may be helpful in selecting patients for entry into adjuvant therapy protocols.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8965593     DOI: 10.1007/bf00571684

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  65 in total

1.  Results of resection of metastatic tumors of the liver.

Authors:  G F WOODINGTON; J M WAUGH
Journal:  Am J Surg       Date:  1963-01       Impact factor: 2.565

2.  Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases.

Authors:  B Cady; M D Stone; W V McDermott; R L Jenkins; A Bothe; P T Lavin; E J Lovett; G D Steele
Journal:  Arch Surg       Date:  1992-05

3.  Hepatic resection for primary and secondary neoplasms of the liver.

Authors:  R F Pommier; E A Woltering; J R Campbell; W S Fletcher
Journal:  Am J Surg       Date:  1987-05       Impact factor: 2.565

4.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

5.  Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma.

Authors:  J T Vetto; K S Hughes; R Rosenstein; P H Sugarbaker
Journal:  Dis Colon Rectum       Date:  1990-05       Impact factor: 4.585

6.  [Surgical treatment of liver metastases from colorectal carcinoma].

Authors:  B Mentges; W Bätz; A Göbel; A Heintz
Journal:  Dtsch Med Wochenschr       Date:  1989-10-13       Impact factor: 0.628

7.  [Resection of liver metastases of colorectal cancers. Results and prognostic factors].

Authors:  D Henne-Bruns; I Vogel; S Schröder; H W Schreiber; B Kremer
Journal:  Chirurg       Date:  1993-04       Impact factor: 0.955

8.  Survival after hepatic resection for malignant tumours.

Authors:  A P Savage; R A Malt
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

9.  Hepatic resection for primary and metastatic tumors.

Authors:  F F Attiyeh; W A Wichern
Journal:  Am J Surg       Date:  1988-11       Impact factor: 2.565

10.  Liver resection for colorectal liver metastases.

Authors:  S Scott; N Carty; L Anderson; I Taylor
Journal:  Eur J Surg Oncol       Date:  1995-02       Impact factor: 4.424

View more
  3 in total

1.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Authors:  M Lorenz; H H Müller; H Schramm; H J Gassel; H G Rau; K Ridwelski; J Hauss; R Stieger; K W Jauch; W O Bechstein; A Encke
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

2.  Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study.

Authors:  Joachim K Seifert; Anna Springer; Philipp Baier; Theodor Junginger
Journal:  Int J Colorectal Dis       Date:  2005-06-23       Impact factor: 2.571

3.  Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.

Authors:  J K Seifert; D L Morris
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.